What's New at The Body
HIV/AIDS News You Can Use
November 1, 2001
New HIV Treatment Drug Gets FDA ApprovalViread, a.k.a. tenofovir, has gotten a thumbs-up from the government for use in HIV treatment. It's the first nucleotide analog drug to receive that honor.
Read The Body's collection of articles about this newly approved drug.
AIDS Through Artists' EyesThe November Visual AIDS Web gallery is now live! This month's curator is Carlos N. Molina, an artist, designer and educator living in New York City. He is currently the editor of SIDAahora, the Spanish-language AIDS magazine published by Body Positive. Click here and browse through his choice of work by Visual AIDS archive members.
Conferences, Conferences, Conferences!Just when is the best time to begin HIV treatment? Can therapy cause as much harm as good in patients who start too early? And just what is "too early," anyway? The answers, as Dr. Pablo Tebas reports, depend on the person. Read about this and much more in The Body's coverage of the 39th Annual Meeting of the Infectious Diseases Society of America.
One of the most important advances in the treatment of hepatitis C has been the development of pegylated interferons. Read Dr. Jorge L. Herrera's coverage of when and how to use them in the Body's conference coverage of the 66th Annual Scientific Meeting of the American College of Gastroenterology.
The numbers are sobering: approximately half of the interviewed HIV-positive patients (around 200 of them) did not notify their sexual partners before embarking on high risk unprotective sex. Dr. Pablo Tebas writes from The Body's coverage of the 39th Annual Meeting of the Infectious Diseases Society of America on a disturbing new report.
Debate rages on over how best to help those impacted by the HIV epidemic in Africa. As Dr. Pablo Tebas reports, some of the doctors most passionately in favor of implementing antiretroviral therapy throughout Africa are realizing just how tough that's going to be. Read about this and much more in The Body's coverage of the 39th Annual Meeting of the Infectious Diseases Society of America.
Researchers are hopeful that tipranavir, a new protease inhibitor in development, will be effective in treating HIV-infected patients who have previously failed other antiretroviral therapies. Dr. Brian A. Boyle reports on the latest developments, as well as other treatment issues, in The Body's coverage of the 8th European Conference on Clinical Aspects and Treatment of HIV-Infection.
Data from two linked presentations by Dr. Steven Grinspoon indicated that certain fats in circulation, known as free fatty acids, may contribute to worsening insulin resistance. Graeme Moyle, M.D. reports from the 3rd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV.
Finding Balance When Living with HIV"AIDS has taught me to focus on the things that I can control -- my attitude, diet, the amount of rest I have, my choice of projects, and the purpose and meaning I find in life." James Monroe Smith shares his thoughts about living with AIDS since 1995, in Body Positive.
A Life-Saving Virus?Two independent studies found that persons with HIV who were also infected with an apparently harmless virus had a much lower death rate than those who were not infected. Read the details in AIDS Treatment News.
Switching Treatments May Be Good for YouEarly results from a Barcelona study show that people who switch treatment regimens every three months may have a better anti-HIV response than those who stick with the same regimen. More on this intriguing study, from Project Inform.
AIDS in Africa: Good News and Bad NewsThe good news: GlaxoSmithKline announced it would allow Africa's largest generic drug maker to manufacture and sell both AZT and 3TC. The bad news: the drugs will still likely cost much more than generics in other countries. This and more on fighting HIV/AIDS in Africa from the latest issue of AIDS Treatment News.
Prison Women and HIV: The Hidden EpidemicFew are aware of the problem, but HIV infection is becoming a major concern among the U.S. women's prison population. Read the details from HIV Education Prison Project News.
Spotlight: the effect of HIV on women who commit crimes -- and are victims of them. Elizabeth Stubblefield provides an overview in HIV Education Prison Project News.
Hepatitis C and Co-InfectionProject Inform provides an extensive fact sheet on the symptoms, transmission, prevention and treatment of hepatitis C in HIV-positive persons.
Q+A: Mouth Care for the HIV-InfectedQ: My mouth has been dry since I have started taking my medications, should I be concerned?
A: Yes, dry mouth is very destructive to your teeth and gums. If this occurs, do not ignore it!
HIV Treatment ALERTS! sits down with Edwin Cordray, D.D.S., to answer some important questions about HIV and the mouth.
Grassroots Advocacy 101A comprehensive guide on how you can make your voice heard in the upper echelons of the U.S. government, from Project Inform.
HIV Prevention in the Catskills"HIV Prevention: Ain't No Mountain High Enough" -- A report from the educational program of Catskills Rural AIDS Services by Marc J. Osterweil and Andrew Weiss, in Body Positive.
Drug Assistance: State by StateNeed help paying for medications? Take a look at the San Francisco AIDS Foundation's listing of AIDS Drug Assistance Programs. (There's one in each state, plus Washington, D.C. and Puerto Rico.)
The Body's News DatabaseMissed one of The Body's weekly updates? Look through our database!
Want to find out the latest news about HIV? Look through our daily news update database.
Understanding the Role of Personality in HIV Risk Behaviors: Implications for Prevention and Treatment